Virtual Medicinal Product (VMP) - Levodopa 20mg/ml / Carbidopa 5mg/ml / Entacapone 20mg/ml intestinal gel 47ml cartridges
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Levodopa 20mg/ml / Carbidopa 5mg/ml / Entacapone 20mg/ml intestinal gel 47ml cartridges | Start Date 01-10-2024 | End Date |
| Abbreviated Name | Abbreviated Name Levodopa 20mg/Carbidopa 5mg/ml/Entacapone 20mg/ml | Start Date 01-10-2024 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 47.0
- UDFS UOM
- ml
- Unit Dose UOM
- cartridge
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intestinal
- Form
- Intestinal gel
- Ontology Form/Route
- intestinalgel.intestinal
- Name Basis
- Other
Codes
- ATC Code
- N04BA03
- BNF Codes
-
- BNF code 04090100
| Code | Start Date | End Date |
|---|---|---|
| 43813711000001100 | 01-10-2024 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Carbidopa monohydrate | Based on Ingredient Substance | 5 mg | 1 ml | |
| Entacapone | Based on Ingredient Substance | 20 mg | 1 ml | |
| Levodopa | Based on Ingredient Substance | 20 mg | 1 ml |
Name
Entacapone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20.0
Strength and UOM (Dmr)
1.0
Name
Levodopa
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20.0
Strength and UOM (Dmr)
1.0
Name
Carbidopa monohydrate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMLevodopa + Carbidopa + Entacapone
-
VMP(Current) Levodopa 20mg/ml / Carbidopa 5mg/ml ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 7 cartridge |